Company: PFSA
Filing Date: 2025-08-25
Form Type: 424B3
Source: 0001213900-25-080387
Chunk: 46

Company: Profusa, Inc.
Filing Date: 2025-08-25
Form: 424B3
Chunk 46
---
 provide, or if the guidance we provide is below the expectations of analysts or investors, the market price of our common stock could decline. 28 If our financial performance fails to meet the expectations of investors and public market analysts, the market price of our common stock could decline. Our revenues and operating results may fluctuate significantly from quarter to quarter. We believe that period -to -periodcomparisons of our operating results may not be meaningful and should not be relied on as an indication of our future performance. If quarterly revenues or operating results fall below the expectations of investors or public market analysts, the trading price of our common stock could decline substantially. Factors that might cause quarterly fluctuations in our operating results include: •our inability to manufacture an adequate supply of product at appropriate quality levels and acceptable costs; •possible delays in our research and development programs or in the completion of any clinical trials; •a lack of acceptance of our products in the marketplace; •the inability of customers to receive reimbursements from third -partypayors; •the purchasing patterns of our customers; •failures to comply with regulatory requirements, which could lead to withdrawal of products from the market; •our failure to continue the commercialization of any of our products; •competition; •inadequate financial and other resources; and •global political and economic conditions, political instability and military hostilities. In the unlikely event that payment of certain outstanding promissory notes issued by Profusa to its founders and insiders is demanded at an inopportune time for Profusa, Profusa management believes it would still have sufficient funds to operate its business, but may need to adjust certain expenditures or raise additional funds to operate at its currently planned levels. Profusa has issued a number of promissory notes to its founders and insiders, which are either payable on demand or past due. As of December 31, 2024, these notes had an aggregate outstanding amount, including principal and accrued interest, of approximately $910,000. Profusa has an understanding with these noteholders that they will withhold from demanding or pursuing repayment until a date to be agreed upon by the parties that will be subsequent to the closing of the Business Combination. However, in the unlikely event that the noteholders demand or pursue repayment of these promissory notes at an inopportune time for Profusa, it is Profusa management’s belief that it would still have sufficient funds to operate its business, but may need to adjust certain expenditures or raise additional funds to operate at its currently planned